Free Trial

Geode Capital Management LLC Raises Stock Position in Molina Healthcare, Inc. (NYSE:MOH)

Molina Healthcare logo with Medical background
Remove Ads

Geode Capital Management LLC grew its holdings in Molina Healthcare, Inc. (NYSE:MOH - Free Report) by 2.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,436,909 shares of the company's stock after acquiring an additional 34,992 shares during the period. Geode Capital Management LLC owned about 2.51% of Molina Healthcare worth $417,144,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Versant Capital Management Inc raised its stake in shares of Molina Healthcare by 83.1% during the 4th quarter. Versant Capital Management Inc now owns 163 shares of the company's stock valued at $47,000 after buying an additional 74 shares during the last quarter. Wingate Wealth Advisors Inc. acquired a new position in shares of Molina Healthcare in the 4th quarter valued at $52,000. EverSource Wealth Advisors LLC boosted its holdings in Molina Healthcare by 81.5% during the fourth quarter. EverSource Wealth Advisors LLC now owns 196 shares of the company's stock worth $57,000 after buying an additional 88 shares in the last quarter. Harvest Fund Management Co. Ltd boosted its holdings in Molina Healthcare by 895.0% during the fourth quarter. Harvest Fund Management Co. Ltd now owns 199 shares of the company's stock worth $58,000 after buying an additional 179 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. increased its holdings in Molina Healthcare by 337.0% in the fourth quarter. Whittier Trust Co. of Nevada Inc. now owns 201 shares of the company's stock valued at $58,000 after buying an additional 155 shares in the last quarter. Institutional investors and hedge funds own 98.50% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

MOH has been the subject of several recent analyst reports. Mizuho lifted their price target on Molina Healthcare from $376.00 to $400.00 and gave the company an "outperform" rating in a research note on Wednesday. Wells Fargo & Company raised Molina Healthcare from an "equal weight" rating to an "overweight" rating and upped their target price for the stock from $295.00 to $372.00 in a research note on Wednesday, March 5th. Barclays dropped their price target on shares of Molina Healthcare from $372.00 to $339.00 and set an "equal weight" rating on the stock in a research note on Friday, February 7th. Guggenheim began coverage on shares of Molina Healthcare in a research report on Wednesday. They issued a "neutral" rating on the stock. Finally, Truist Financial decreased their price target on shares of Molina Healthcare from $370.00 to $340.00 and set a "buy" rating on the stock in a research note on Wednesday, February 19th. Eight research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $350.75.

Get Our Latest Stock Analysis on Molina Healthcare

Molina Healthcare Trading Down 0.2 %

MOH stock traded down $0.52 during mid-day trading on Thursday, hitting $339.57. 188,793 shares of the company were exchanged, compared to its average volume of 742,926. Molina Healthcare, Inc. has a 12-month low of $262.32 and a 12-month high of $379.07. The firm has a market capitalization of $18.57 billion, a P/E ratio of 16.61, a PEG ratio of 1.06 and a beta of 0.70. The business has a fifty day simple moving average of $309.45 and a 200-day simple moving average of $308.20. The company has a quick ratio of 1.62, a current ratio of 1.62 and a debt-to-equity ratio of 0.69.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its quarterly earnings results on Wednesday, February 5th. The company reported $5.05 EPS for the quarter, missing analysts' consensus estimates of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. On average, equities research analysts predict that Molina Healthcare, Inc. will post 24.4 earnings per share for the current fiscal year.

Insider Transactions at Molina Healthcare

In other Molina Healthcare news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $301.33, for a total value of $301,330.00. Following the sale, the director now directly owns 17,375 shares of the company's stock, valued at approximately $5,235,608.75. This represents a 5.44 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 1.10% of the company's stock.

About Molina Healthcare

(Free Report)

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.

Recommended Stories

Institutional Ownership by Quarter for Molina Healthcare (NYSE:MOH)

Should You Invest $1,000 in Molina Healthcare Right Now?

Before you consider Molina Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.

While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads